BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/12/2020 11:28:25 AM | Browse: 1373 | Download: 2715
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 51571
Country Japan
ISSN 1948-5204 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer
Manuscript Source Invited Manuscript
All Author List Kei Kimura, Naohito Beppu, Hiroshi Doi, Kozo Kataoka, Tomoki Yamano, Motoi Uchino, Masataka Ikeda, Hiroki Ikeuchi and Naohiro Tomita
ORCID
Author(s) ORCID Number
Kei Kimura http://orcid.org/0000-0002-4646-667X
Naohito Beppu http://orcid.org/0000-0001-7442-2765
Hiroshi Doi http://orcid.org/0000-0003-3237-2119
Kozo Kataoka http://orcid.org/0000-0003-2043-8184
Tomoki Yamano http://orcid.org/0000-0002-6607-3590
Motoi Uchino http://orcid.org/0000-0002-2934-1680
Masataka Ikeda http://orcid.org/0000-0003-1893-8171
Hiroki Ikeuchi http://orcid.org/0000-0001-9144-5782
Naohiro Tomita http://orcid.org/0000-0002-0963-1533
Funding Agency and Grant Number
Corresponding Author Kei Kimura, MD, PhD, Assistant Professor, Doctor, Doctor, Division of Lower Gastrointestinal Surgery, Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 661-8501, Hyogo, Japan. k-kimura@hyo-med.ac.jp
Key Words Preoperative chemoradiotherapy; Rectal cancer; Irinotecan; Tegafur/gimeracil/oteracil; Neoadjuvant chemoradiotherapy; Radiation therapy
Core Tip Lower advanced rectal cancer located within 8 cm of the anal verge carries a higher risk of local recurrence. The aim of this single-center retrospective study was to assess the clinical outcomes of patients with locally advanced rectal cancer treated preoperative chemoradiotherapy using tegafur/gimeracil/oteracil plus irinotecan. Grade 3 or 4 toxicity was mild and led to good relative dose intensity with on-schedule treatment. Also, we investigated the risk factors for local recurrence-free survival and relapse-free survival. Multivariate analysis detected no factors for local recurrence-free survival. Our study confirmed good compliance and favorable tumor regression.
Publish Date 2020-03-12 11:28
Citation Kimura K, Beppu N, Doi H, Kataoka K, Yamano T, Uchino M, Ikeda M, Ikeuchi H, Tomita N. Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer. World J Gastrointest Oncol 2020; 12(3): 311-322
URL https://www.wjgnet.com/1948-5204/full/v12/i3/311.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i3.311
Full Article (PDF) WJGO-12-311.pdf
Full Article (Word) WJGO-12-311.docx